Ayer Capital Partners, Llc - Net Worth and Insider Trading

Ayer Capital Partners, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ayer Capital Partners, Llc owns 4 companies in total, including Iovance Biotherapeutics Inc (IOVA) , Insmed Inc (INSM) , and Abeona Therapeutics Inc (ABEO) among others .

Click here to see the complete history of Ayer Capital Partners, Llc’s form 4 insider trades.

Insider Ownership Summary of Ayer Capital Partners, Llc

Ticker Comapny Transaction Date Type of Owner
IOVA Iovance Biotherapeutics Inc 2013-05-22 10 percent owner
INSM Insmed Inc 2012-09-28 10 percent owner
ABEO Abeona Therapeutics Inc 2011-11-02 10 percent owner
LIMIT LIMIT 2011-05-21 10 percent owner

Ayer Capital Partners, Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Ayer Capital Partners, Llc Ownership Network

Ownership Network List of Ayer Capital Partners, Llc

No Data

Ownership Network Relation of Ayer Capital Partners, Llc

Insider Network Chart

Ayer Capital Partners, Llc Owned Company Details

What does Iovance Biotherapeutics Inc do?

Who are the key executives at Iovance Biotherapeutics Inc?

Ayer Capital Partners, Llc is the 10 percent owner of Iovance Biotherapeutics Inc. Other key executives at Iovance Biotherapeutics Inc include General Counsel Frederick G Vogt , Chief Operating Officer Igor Bilinsky , and Chief Financial Officer Jean-marc Bellemin .

Iovance Biotherapeutics Inc (IOVA) Insider Trades Summary

Over the past 18 months, Ayer Capital Partners, Llc made no insider transaction in Iovance Biotherapeutics Inc (IOVA). Other recent insider transactions involving Iovance Biotherapeutics Inc (IOVA) include a net purchase of 10,000,000 shares made by Wayne P. Rothbaum , and a net purchase of 260,000 shares made by Merrill A Mcpeak .

In summary, during the past 3 months, insiders sold 0 shares of Iovance Biotherapeutics Inc (IOVA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Iovance Biotherapeutics Inc (IOVA) were sold and 10,260,000 shares were bought by its insiders, resulting in a net purchase of 10,260,000 shares.

Iovance Biotherapeutics Inc (IOVA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Iovance Biotherapeutics Inc Insider Transactions

No Available Data

Ayer Capital Partners, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Ayer Capital Partners, Llc. You might contact Ayer Capital Partners, Llc via mailing address: 230 California Street, Suite 600, San Francisco Ca 94111.